MedPath

Dopaminergic modulation of neuronal response to a stimulus-reward task in people with 22q11 deletion syndrome and healthy volunteers: a functional MRI study.

Conditions
delusion
psychosis
10013511
Registration Number
NL-OMON29870
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

20 individuals with 22q11 deletion syndrome with no psychiatric history and no use of psychiatric medication, age 18 till 50 years.
20 healthy volunteers, matched for age and gender, with no psychiatric history and no use of psychiatric medication.

Exclusion Criteria

Pregnancy, presence of metals that are not allowed in MRI-investigation.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Blood oxygen level dependent (BOLD) contrast measured during a modified<br /><br>reversal learning task within the MRI scanner. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>1. Level of catecholamine synthesis, measured by blood levels of:<br /><br>* homovanillic acid (HVA)<br /><br>* 3-methoxy-4 hydroxyphenethyleneglycol (MHPG),<br /><br>* VMA<br /><br>* prolactine<br /><br><br /><br>and urine levels of:<br /><br>* HVA<br /><br>* MHPG<br /><br>* VMA<br /><br>* dopamine (free and conjungated) and norepinephrine (free and conjungated)<br /><br><br /><br>2. Score on modified reversal learning taak<br /><br>3. Possible extrapyramidal side-effects<br /><br>4. Subjective experiences<br /><br>5. Depressive and positive and negative symptoms </p><br>
© Copyright 2025. All Rights Reserved by MedPath